Skip to main content
Journal cover image

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

Publication ,  Journal Article
Ulloa, L; Doody, J; Massagué, J
Published in: Nature
February 1999

Transforming growth factor-beta (TGF-beta) and interferon-gamma (IFN-gamma) have opposite effects on diverse cellular functions, but the basis for this antagonism is not known. TGF-beta signals through a receptor serine kinase that phosphorylates and activates the transcription factors Smads 2 and 3, whereas the IFN-gamma receptor and its associated protein tyrosine kinase Jak1 mediate phosphorylation and activation of the transcription factor Stat1. Here we present a basis for the integration of TGF-beta and IFN-gamma signals. IFN-gamma inhibits the TGF beta-induced phosphorylation of Smad3 and its attendant events, namely, the association of Smad3 with Smad4, the accumulation of Smad3 in the nucleus, and the activation of TGFbeta-responsive genes. Acting through Jak1 and Stat1, IFN-gamma induces the expression of Smad7, an antagonistic SMAD, which prevents the interaction of Smad3 with the TGF-beta receptor. The results indicate a mechanism of transmodulation between the STAT and SMAD signal-transduction pathways.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nature

DOI

EISSN

1476-4687

ISSN

0028-0836

Publication Date

February 1999

Volume

397

Issue

6721

Start / End Page

710 / 713

Related Subject Headings

  • Transforming Growth Factor beta
  • Trans-Activators
  • Smad7 Protein
  • Smad3 Protein
  • Signal Transduction
  • STAT1 Transcription Factor
  • Receptors, Transforming Growth Factor beta
  • Protein-Tyrosine Kinases
  • Phosphorylation
  • Molecular Sequence Data
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ulloa, L., Doody, J., & Massagué, J. (1999). Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature, 397(6721), 710–713. https://doi.org/10.1038/17826
Ulloa, L., J. Doody, and J. Massagué. “Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.Nature 397, no. 6721 (February 1999): 710–13. https://doi.org/10.1038/17826.
Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999 Feb;397(6721):710–3.
Ulloa, L., et al. “Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.Nature, vol. 397, no. 6721, Feb. 1999, pp. 710–13. Epmc, doi:10.1038/17826.
Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999 Feb;397(6721):710–713.
Journal cover image

Published In

Nature

DOI

EISSN

1476-4687

ISSN

0028-0836

Publication Date

February 1999

Volume

397

Issue

6721

Start / End Page

710 / 713

Related Subject Headings

  • Transforming Growth Factor beta
  • Trans-Activators
  • Smad7 Protein
  • Smad3 Protein
  • Signal Transduction
  • STAT1 Transcription Factor
  • Receptors, Transforming Growth Factor beta
  • Protein-Tyrosine Kinases
  • Phosphorylation
  • Molecular Sequence Data